Kevin Michael Sweet, MS

Kevin Michael Sweet, MS

Academic Title: Professor in the College of Medicine

Research Program: Molecular Carcinogenesis and Chemoprevention

Contact Information
  • About Me

    I am a professor in the Department of Internal Medicine, Division of Human Genetics at The Ohio State University College of Medicine and have worked with colleagues in Ohio State’s College of Public Health and the Cancer Control Program at the OSUCCC – James for more than 20 years. I have more than 26 years of experience as a practicing genetic counselor and researcher, contributing to numerous clinical, translational, discovery, review and guideline publications on cancer genetics, genetic counseling service delivery and precision medicine.

    My research focus is on articulating, developing and evaluating alternative models of genetic counseling that capitalize on new technologies and accommodate a more patient-driven approach to precision medicine. I served as principal investigator on a National Human Genome Research Institute (NHGRI)-funded R21 study that focused on the development of a novel genetic counseling patient preference (GCPP) framework. The GCPP honors patient preferences to leverage patient-centered IT (e.g., electronic health record (EHR) portals, mobile applications) to increase access to genetic testing and the provision of post-genetic test counseling.

    One of my current projects is funded by a five-year R01 grant as part of the Cancer Moonshot Research Initiative from the National Cancer Institute. This project uses randomized controlled trial (RCT) design to compare traditional genetic counseling/testing to a GCPP intervention using the EPIC EHR portal, with the ultimate goal of improving the genetic counseling experience among women with elevated breast cancer risk. Results from this study will provide an evidence base that can guide changes in the delivery of genetic counseling and inform best practices.

    I am also currently working on development of a fourth-generation family history risk assessment application available through The James. Family Health Risk Calculator, formerly known as Family HealthLink, is a web application powered by cancer and cardiovascular disease algorithms that triages family history information entered by patients/general public and provides referral recommendations for genetic counseling and testing.

    I have authored or co-authored numerous articles in such scientific publications as JAMA, Genetics in Medicine, Journal of Clinical Oncology, Clinical Genetics, Journal of Genetic Counseling and International Journal of Cancer. Additionally, I am a member of several professional organizations, including the American Society of Human Genetics and the National Society of Genetic Counselors.

  • Education & Training

    Undergraduate Degree - BS

    • University of Wisconsin-Milwaukee
      Milwaukee, WI
      USA

    Graduate Program - MS

    • Sarah Lawrence College
      Bronxville, NY
      USA
  • Academic Office & Contact Information

    Academic Office:

    Kenny Rd, 2006-2030
    2006-2030 Kenny Rd
    Columbus, Ohio 43221-3502

  • Publications

    September 1, 2023

    Genetic counseling and testing for females at elevated risk for breast cancer: Protocol for the randomized controlled trial of the know your risk intervention.

    Sweet K, Reiter PL, Schnell PM, Senter L, Shane-Carson KP, Aeilts A, Cooper J, Spears C, Brown J, Toland AE, Agnese DM, Katz ML

    Contemporary Clinical Trials

    October 29, 2022

    Development of a web-based, theory-guided narrative intervention for women at elevated risk for breast cancer.

    Katz ML, Senter L, Reiter PL, Emerson B, Ennis AC, Shane-Carson KP, Aeilts A, Cassingham HR, Schnell PM, Agnese DM, Toland AE, Sweet K

    Patient Educ Couns

    January 5, 2022

    Hospital-based ovarian cancer patient traceback program results in minimal genetic testing uptake.

    Weinmann S, Phillips S, Sweet K, Cosgrove CM, Senter L

    Gynecol Oncol

    April 2, 2021

    mTOR inhibitors reduce enteropathy, intestinal bleeding and colectomy rate in juvenile polyposis of infancy due to PTEN-BMPR1A deletion syndrome.

    Taylor H, Yerlioglu D, Phen C, Ballauff A, Nedelkopoulou N, Spier I, Loverdos I, Busoni VB, Heise J, Dale P, Meij T, Sweet K, Cohen MC, Fox VL, Mas E, Aretz S, Eng C, Buderus S, Thomson M, Rojas I, Uhlig HH

    Hum Mol Genet